Question to the Department for Business and Trade:

To ask the Secretary of State for Business and Trade, whether the Government has made an assessment of the impact of pre-grant oppositions in India on access to medicine.

The UK’s approach to intellectual property (IP) with all partners is to strike a balance between rewarding research and innovation, which can benefit all countries, whilst reflecting wider public interests such as ensuring access to medicines.

We do not comment on specifics of live negotiations.